Single-cell analysis of severe COVID-19 patients reveals a monocyte-driven inflammatory storm attenuated by Tocilizumab
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Despite the current devastation of the COVID-19 pandemic, several recent studies have suggested that the immunosuppressive drug Tocilizumab can powerfully treating inflammatory responses that occur in this disease. Here, by employing single-cell analysis of the immune cell composition of severe-stage COVID-19 patients and these same patients in post Tocilizumab-treatment remission, we have identified a monocyte subpopulation specific to severe disease that contributes to inflammatory storms in COVID-19 patients. Although Tocilizumab treatment attenuated the strong inflammatory immune response, we found that immune cells including plasma B cells and CD8 + T cells still exhibited an intense humoral and cell-mediated anti-virus immune response in COVID-19 patients after Tocilizumab treatment. Thus, in addition to providing a rich, very high-resolution data resource about the immune cell distribution at multiple stages of the COVID-19 disease, our work both helps explain Tocilizumab’s powerful therapeutic effects and defines a large number of potential new drug targets related to inflammatory storms.
Article activity feed
-
SciScore for 10.1101/2020.04.08.029769: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources The thickness of line connecting TFs and target genes represented the weight of regulatory link predicted by SCENIC. SCENICsuggested: (SCENIC, RRID:SCR_017247)In CellphoneDB, a permutation test was used to evaluate the significance of a cytokine/receptor pair. CellphoneDBsuggested: (CellPhoneDB, RRID:SCR_017054)Metascape utilizes the hypergeometric test and Benjamini-Hochberg P value correction algorithm to identify the ontology terms that contain a statistically greater number of genes in common than expected. Metascapesuggested: (Metascape, RRID:SCR_016620)Data Availability: The scRNA-seq … SciScore for 10.1101/2020.04.08.029769: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources The thickness of line connecting TFs and target genes represented the weight of regulatory link predicted by SCENIC. SCENICsuggested: (SCENIC, RRID:SCR_017247)In CellphoneDB, a permutation test was used to evaluate the significance of a cytokine/receptor pair. CellphoneDBsuggested: (CellPhoneDB, RRID:SCR_017054)Metascape utilizes the hypergeometric test and Benjamini-Hochberg P value correction algorithm to identify the ontology terms that contain a statistically greater number of genes in common than expected. Metascapesuggested: (Metascape, RRID:SCR_016620)Data Availability: The scRNA-seq data of PBMCs from the 2 severe COVID-19 patients can be obtained from the Genome Sequence Archive (GSA) at BIG Data Center and the accession number is CRA002509. Genome Sequence Archivesuggested: NoneResults from OddPub: Thank you for sharing your code and data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
